Skip To Main Content
Seokhyeong Go on Muck Rack

Seokhyeong Go

As seen in: Wiley Online Library, Cell Reports Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Seokhyeong

Contact Seokhyeong, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy

|
By Junha Cha, Chang Gon Kim, Nam Suk Sim, Gamin Kim, Jaehyung Kim, Jinna Kim, Sun Och Yoon, Seokhyeong Go, Jeongah Kim, Seungbyn Baek, Kyung Hwan Kim, Yoon Koh, Insuk Lee, Hye Ryun Kim, Wonrak Son, Yurim Jung, Hyun Jun Hong, Hae Been Lee, Euijung Seong
| Cell Reports Medicine Verified
Keywords immunotherapy immune checkpoint inhibitor dual ICB durvalumab tremelimumab head and neck squamous cell carcinoma progenitor exhausted T single-cell RNA single-cell TCR Introduction Head and neck cancer is a type of malignancy, with squamous cell carcinoma accounting for over 90% of cases.1 Recently approved immune checkpoint inhibitors (ICIs) such as nivolumab and pembrolizumab have changed treatment plan for recurrent and metastatic head and neck squamous carcinoma (R/M HNSCC).
Open in Who Shared Issue with article?

A Personalized Cancer Nanovaccine that Enhances T‐Cell Responses and Efficacy through Dual Interactions with Dendritic Cells and T Cells

|
By Byung-Soo Kim, Mungyo Jung, Suyoung Lee, Seokhyeong Go
| pericles.pericles-prod.literatumonline.com
Research Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.
Open in Who Shared Issue with article?

A Personalized Cancer Nanovaccine that Enhances T‐Cell Responses and Efficacy through Dual Interactions with Dendritic Cells and T Cells

|
By Byung-Soo Kim, Seokhyeong Go, Mungyo Jung, Suyoung Lee
| Wiley Online Library Verified
Research Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.
Open in Who Shared Issue with article?
See all 3 articles